Harrow Health shares are trading lower after the company reported Q2 financial results and issued FY23 guidance.
Portfolio Pulse from Benzinga Newsdesk
Harrow Health has reported its Q2 financial results and issued FY23 guidance, which has led to a decrease in its share price.
August 10, 2023 | 7:09 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Harrow Health's stock price is trading lower after the company reported its Q2 financial results and issued FY23 guidance.
The company's Q2 financial results and FY23 guidance are key factors that investors consider when making investment decisions. The negative reaction suggests that the results or guidance did not meet market expectations, leading to a decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100